2-mercaptomethyl-3-guanidinoethylthiopropionic acid has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahamsson, TI; Björkman, JA; Mattsson, CJ; Nerme, VK | 1 |
| Adam, A; Closset, J; Couture, R; Décarie, A; Drapeau, G | 1 |
| Baum, HP; Bitter-Suermann, D; Böttger, EC; Hadding, U; Hoffmann, T; Messner, M | 1 |
3 other study(ies) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.
Topics: 3-Mercaptopropionic Acid; Animals; Carboxypeptidase B2; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Female; Fibrinolysis; Fibrinolytic Agents; Lysine Carboxypeptidase; Male; Plasminogen Activators; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator | 2005 |
Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues.
Topics: 3-Mercaptopropionic Acid; Acute Disease; Amino Acid Sequence; Animals; Bradykinin; Captopril; Digoxigenin; Disease Models, Animal; Immunoenzyme Techniques; Inflammation; Luminescent Measurements; Lysine Carboxypeptidase; Male; Molecular Sequence Data; Molecular Structure; Rats; Rats, Wistar | 1994 |
In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
Topics: 3-Mercaptopropionic Acid; Anaphylatoxins; Animals; Complement C3; Complement C3a; Disease Models, Animal; Dose-Response Relationship, Immunologic; Guinea Pigs; Inflammation; Leukocyte Count; Lung; Lung Diseases; Lysine Carboxypeptidase; Neutropenia; Neutrophils; Platelet Count; Time Factors | 1988 |